Table 5. Existing collaborative practice agreements (CPAs) (n=40).
Collaborative practice agreements (CPA) exist for the following conditions: | N (%) |
---|---|
Anticoagulation | 12 (30%) |
Asthma | 18 (45%) |
COPD | 16 (40%) |
Depression | 12 (30%) |
Diabetes | 27 (67.5%) |
Dyslipidemia | 23 (57.5%) |
Flu/antiviral | 3 (7.5%) |
GERD | 11 (27.5%) |
Hypertension | 29 (72.5%) |
Hypothyroidism | 19 (47.5%) |
Pain | 15 (37.5%) |
Tobacco cessation | 26 (65%) |
Currently no CPAs are in place | 6 (15%) |